LINTHICUM, Md., Feb. 13, 2007 (PRIME NEWSWIRE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the acquisition of a dialysis center in Columbus, OH. The center has a total of twenty-one treatment stations, and an anticipated initial patient census of between 42 and 45 patients. Columbus has been an area of interest for the company for some time and this facility, along with the company's Delaware County facility currently under development, will provide the type of initial market penetration the company desires.
President & CEO Stephen Everett commented "We remain optimistic about the opportunities that exist in the area and are excited to be adding more talented clinical staff to the DCA team. This acquisition is directly in line with the strategies we have developed for the managed growth of our Mid-West market, and our company."
Dialysis Corporation of America currently owns or manages 33 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina providing patients with a full range of quality in-center, and at-home hemodialysis services, as well as providing in-hospital services in many of our markets. With the completion of the centers under development, DCA will have 35 centers in operation.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, maintaining continued growth and profitability, delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's dialysis facilities can mature to provide profitability, the extensive regulation of dialysis operations, government rate determination for Medicare reimbursement, pricing pressure from private payors, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2005. The historical results contained in this press release are not necessarily indicative of future performance of the company.
The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.